The Culture Of Change: Pfizer's Workforce Challenge
This article was originally published in Scrip
Pharmaceutical firms boast a wealth of experience in M&A thanks in no small part to a boom in activity over the past year, but the struggle to prevent value leaking from a deal remains a major challenge. The huge scale of the potential deal between Pfizer Inc. and Allergan PLC dramatically raises the stakes.
Register for our free email digests: